Advanced Proteome Therapeutics (STU:0E81) FCF Margin %: 0.00% (As of Apr. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Advanced Proteome Therapeutics FCF Margin %?

Advanced Proteome Therapeutics STU:0E81 FCF Margin % is 0.00% as of Apr. 2023.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Advanced Proteome Therapeutics's Free Cash Flow for the three months ended in Apr. 2023 was €-0.65 Mil. Advanced Proteome Therapeutics's Revenue for the three months ended in Apr. 2023 was €0.00 Mil. Therefore, Advanced Proteome Therapeutics's FCF Margin % for the quarter that ended in Apr. 2023 was 0.00%.

As of today, Advanced Proteome Therapeutics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Advanced Proteome Therapeutics's FCF Margin % or its related term are showing as below:


STU:0E81's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -81.28
* Ranked among companies with meaningful FCF Margin % only.

Advanced Proteome Therapeutics FCF Margin % Related Terms

Advanced Proteome Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Advanced Proteome Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Proteome Therapeutics FCF Margin % Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:0E81 vs VRTX, REGN, SGEN: FCF Margin % Comparison

For the Biotechnology subindustry, Advanced Proteome Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Proteome Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's FCF Margin % falls into.


Advanced Proteome Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Advanced Proteome Therapeutics's FCF Margin for the fiscal year that ended in Jul. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Jul. 2022 )/Revenue (A: Jul. 2022 )
=-0.696/0
= %

Advanced Proteome Therapeutics's FCF Margin for the quarter that ended in Apr. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Apr. 2023 )/Revenue (Q: Apr. 2023 )
=-0.649/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Advanced Proteome Therapeutics (STU:0E81) has a FCF Margin % of 0.00% as of Apr. 2023. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Advanced Proteome Therapeutics and its competitors.
Is Advanced Proteome Therapeutics' FCF Margin % too high?
Advanced Proteome Therapeutics' current FCF Margin % is 0.00%.
How does Advanced Proteome Therapeutics' FCF Margin % compare to VRTX and REGN?
Advanced Proteome Therapeutics' FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Advanced Proteome Therapeutics and its competitors. Advanced Proteome Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Proteome Therapeutics stock overvalued right now?
Advanced Proteome Therapeutics (STU:0E81) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Advanced Proteome Therapeutics (STU:0E81), the current FCF Margin % is 0.00% as of Apr. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced Proteome Therapeutics Business Description

Address 104 8337 Eastlake Drive, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.